By activating the NF-κB and TGF-β/Smad pathways synchronously, platelet-derived TGF-β and direct platelet-tumor cell contacts can induce mesenchymal-like transition and promote metastasis in cancer cells (23, 24). Here, NFKB1 is linked to cancer.